Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks
Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital Management, a quantitative hedge fund.
Posts Tagged ‘Bristol-Myers Squibb Company (NYSE:BMY)’
Is Bristol-Myers Squibb Company (BMY) Stock at Risk From Proposed Medicare Drug Price Negotiation Updates?
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now.
12 Best Low-Priced Pharma Stocks to Buy Right Now
Investors looking for large returns without making a sizable initial commitment are still drawn to low-priced companies.
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On
On May 27, Reuters reported that Biohub, a philanthropic venture formed by Meta CEO Mark Zuckerberg and Dr.
12 Most Undervalued Stocks to Invest In
Undervalued stocks are getting more attention as investors look for opportunities outside the crowded growth trade.
BMO Capital Maintains Market Perform Rating on Bristol-Myers (BMY) After Earnings Beat
Bristol-Myers Squibb Company (NYSE:BMY) ranks among the best retirement stocks to buy now.
8 Best Retirement Stocks to Buy Now
A great many people struggle to determine how much money they will need to live comfortably in retirement, especially as retirement expenses rise annually.
12 Best Dividend Stocks to Invest In According to Hedge Funds
Investors tend to favor dividend stocks in times of market volatility and economic uncertainty, as we have seen in recent months.
10 Best Biotech Stocks to Invest In According to Billionaire Steve Cohen
On April 30, Bloomberg reported that Steve Cohen resigned as president of Point72 Asset Management, and Harry Schwefel was appointed co-CIO.
14 Best Defensive Stocks to Invest In Now
The US economy has entered the final week of April navigating a precarious war-driven landscape that has fundamentally altered the outlook for both growth and monetary policy.
15 Cash-Rich Dividend Stocks to Invest In Right Now
On March 24, Reuters reported that Barclays raised its 2026 year-end S&P 500 target.
15 Blue Chip Stocks with Highest Dividends
Blue-chip stocks refer to shares of large, well-established companies that lead their industries.
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial of Camzyos
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best pharma stocks to invest in now. Bristol-Myers Squibb Company (NYSE:BMY) announced on March 29 positive data from the...
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
15 Large-cap Stocks with Highest Dividends
Large-cap stocks are usually issued by established companies with long track records. These are often well-known names that have been operating for years.
Bristol-Myers Squibb (BMY) Faces Mixed Analyst Sentiment Despite Strong Momentum in Healthcare Industry
Bristol-Myers Squibb Company (NYSE:BMY) is facing mixed analyst sentiment, with roughly 60% of covering analysts maintaining mixed ratings on the stock.
Top 10 Stocks to Invest in For Financial Stability
According to the report, geopolitical tensions, particularly the ongoing armed conflict in Iran, are weighing heavily on economists, who believe higher oil prices and broader ...
Jim Cramer Broke Down 16 Stocks Including Pharma Plays for Rising Oil
In this article, we will look at Jim Cramer’s breakdown of 16 stocks, including pharma plays for rising oil.
Piper Sandler Sees Path to Growth for Bristol-Myers Squibb Company (BMY) After Eliquis Patent Expiry
On February 23, Piper Sandler boosted its price target for Bristol-Myers Squibb Company (NYSE:BMY) to $75 from $66 while keeping an Overweight rating on the company's shares.
UBS Boosts Bristol-Myers Squibb (BMY) Price Target as Milvexian Data Looms
On March 6, UBS raised its price recommendation on Bristol-Myers Squibb Company (NYSE:BMY) to $70 from $65 and maintained a Buy rating on the shares.
14 Stocks on the Verge of Becoming Dividend Aristocrats
A February 26 report from CNBC said investors looking for stability have increasingly turned to companies with consistent dividend payments.
Starter Stock Portfolio: 14 Safe Stocks to Buy Now
Global stock markets have continued to struggle as oil prices surged to their highest weekly spike in six years, with no signs of an imminent end to the Middle East conflict.
RBC Capital Initiates Bristol Myers (BMY) with $60 Target, Cites Late-Stage Pipeline Depth
On February 25, RBC Capital initiated coverage of Bristol-Myers Squibb Company (NYSE:BMY) with a Sector Perform rating and a $60 price target.
14 Best Affordable Dividend Stocks to Buy According to Analysts
According to a report from Franklin Templeton, dividends have played a much larger role in investor returns than many people realize.
FDA Accepts Bristol Myers Squibb (BMY) NDA for Iberdomide With Priority Review
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best value stocks to buy now.
11 Best Value Stocks to Buy Now
On February 7, Richard Bernstein, the CEO of Richard Bernstein Advisors, joined 'The Exchange' on CNBC to discuss the current state of the equity markets and his firm's macro-...
Barclays Initiates Bristol Myers (BMY) with Overweight Rating on Pipeline Potential
On February 20, Barclays began coverage of Bristol-Myers Squibb Company (NYSE:BMY) with an Overweight rating and a $75 price target.
14 Best Low Volatility Dividend Stocks to Invest In
Morgan Stanley’s Global Investment Committee believes the current bull market still has room to run and could extend into a fourth year.
What Does the Street Have to Say About Bristol-Myers Squibb Company (BMY)?
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best immunotherapy stocks to buy according to hedge funds.
12 Best Immunotherapy Stocks to Buy According to Hedge Funds
On February 13, Matt Orton, Raymond James Investment Management's chief market strategist, appeared on CNBC’s ‘The Exchange’ to talk about the recent trends in equity markets...
Here’s What Analysts Are Saying About Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best medical research stocks to buy according to hedge funds.
10 Best Medical Research Stocks to Buy According to Hedge Funds
On January 27, Sarah James, Cantor Fitzgerald analyst, appeared on CNBC’s ‘Squawk on the Street’ to talk about the healthcare insurance sector and the stocks coming under...
Bristol-Myers Squibb Company (BMY) Growth Portfolio Driving Earnings Growth
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best long-term stocks to invest in for retirement.
12 Best Long-Term Stocks to Invest in for Retirement
Days are gone when investors simply put money into fixed-income assets for their appealing yields, generating solid streams of income to finance a comfortable retirement.
Guggenheim Raises its Price Target on Bristol-Myers Squibb Company (BMY) to $72 and Reiterates a Buy Rating
On February 6, 2026, Guggenheim raised its price target on Bristol-Myers Squibb Company (NYSE:BMY) to $72 from $62 and reiterated a Buy rating.
10 Most Profitable Undervalued Stocks to Buy
Profitability has moved back into focus amid an environment where interest rates remain well above the levels seen for much of the past decade.
Jim Cramer Discusses Bristol Myers’s (BMY) Cobenfy Drug
Bristol Myers Squibb Company (NYSE:BMY) is one of the largest pharmaceutical companies in the world. Its shares are up by 7.5% over the past year and by 15.4% year-to-date.
12 Stocks Jim Cramer Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed remarks made by Republican Senator Tim Scott (R-S.C.).
Bristol-Myers Squibb (BMY) Poised for Upside With Registrational Data Ahead
Bristol-Myers Squibb Company (NYSE:BMY) ranks among the stocks with the lowest forward PE ratios.
Piper Sandler Raises Bristol Myers (BMY) PT to $66 Citing Pipeline Visibility
Bristol Myers Squibb Company (NYSE:BMY) is one of the most undervalued large cap stocks to invest in now.
20 Stocks with the Lowest Forward PE Ratio
Stocks fell on January 30 as the technology sector remained weak, despite President Donald Trump's appointment of Kevin Warsh to lead the Federal Reserve.
Citi Raises Bristol-Myers (BMY) Target as Sector Outlook Improves into 2026
On January 27, Citi analyst Geoff Meacham raised his price objective on Bristol-Myers Squibb Company (NYSE:BMY) to $60 from $53.
15 Most Undervalued Large Cap Stocks to Invest In Now
On January 21, Morgan Stanley chairman and CEO Ted Pick joined CNBC's 'Squawk Box' to discuss the latest market trends and suggested that the corporate health of large cap companies...
14 High Yield Dividend Stocks with Sustainable Payouts
Dividends have been doing a lot of the quiet work in investing for a long time.
Bristol Myers Squibb (BMY), Microsoft (MSFT) Partner to Enhance Early Lung Cancer Detection Through AI
Bristol-Myers Squibb Company (NYSE:BMY) is one of the best inexpensive stocks to buy now.
Janux Therapeutics Partners With Bristol-Myers (BMY) on Solid Tumor Therapy
Janux Therapeutics said on January 22 that it has partnered with Bristol-Myers Squibb Company (NYSE:BMY) to develop a new cancer treatment, according to Reuters.
Retirement Stock Portfolio: 12 Low Risk Investments
Planning for retirement often pushes investors to favor stability over big swings.
11 Best Inexpensive Stocks to Buy Now
On January 16, Saira Malik, Nuveen CIO, joined CNBC's 'Closing Bell' to discuss her belief that earnings would propel the market forward, but valuations could bring volatility...
Bristol-Myers (BMY): UBS Turns Bullish as Biotech and Pharma Show Signs of a Recovery
On January 7, UBS upgraded Bristol-Myers Squibb Company (NYSE:BMY) to a Buy from Neutral. The firm lifted its price target sharply to $65, from $46.
Leerink Bullish on Bristol-Myers Squibb Company (BMY) Amid Ample Pipeline Optionality in 2026
On January 13, 2026, Leerink raised its price target on Bristol-Myers Squibb Company (NYSE:BMY) from $54.00 to $60.00, while reiterating an ‘Outperform’ rating.
Hedge Fund Resource Center
